CALGB 80403/ECOG 1206: A randomized phase II study of three standard chemotherapy regimens (ECF, IC, FOLFOX) plus cetuximab in metastatic esophageal and GE junction cancer
- Citation:
- J Clin Oncol vol 28 (15s) abstr 4006
- Meeting Instance:
- ASCO 2010
- Year:
- 2010
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2410
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- P. C. Enzinger B. Burtness D. R. Hollis D. Niedzwiecki D. H. Ilson A. B. Benson 3rd R. J. Mayer R. M. Goldberg
- Networks:
- Study
- CALGB-80403
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: